Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model
- PMID: 10964604
- DOI: 10.1006/nbdi.2000.0304
Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model
Erratum in
- Neurobiol Dis 2000 Dec;7(6 Pt B):690
Abstract
Recent data suggest that cholesterol metabolism is linked to susceptibility to Alzheimer's disease (AD). However, no direct evidence has been reported linking cholesterol metabolism and the pathogenesis of AD. To test the hypothesis that amyloid beta-peptide (Abeta) deposition can be modulated by diet-induced hypercholesterolemia, we used a transgenic-mouse model for AD amyloidosis and examined the effects of a high-fat/high-cholesterol diet on central nervous system (CNS) Abeta accumulation. Our data showed that diet-induced hypercholesterolemia resulted in significantly increased levels of formic acid-extractable Abeta peptides in the CNS. Furthermore, the levels of total Abeta were strongly correlated with the levels of both plasma and CNS total cholesterol. Biochemical analysis revealed that, compared with control, the hypercholesterolemic mice had significantly decreased levels of sAPPalpha and increased levels of C-terminal fragments (beta-CTFs), suggesting alterations in amyloid precursor protein processing in response to hypercholesterolemia. Neuropathological analysis indicated that the hypercholesterolemic diet significantly increased beta-amyloid load by increasing both deposit number and size. These data demonstrate that high dietary cholesterol increases Abeta accumulation and accelerates the AD-related pathology observed in this animal model. Thus, we propose that diet can be used to modulate the risk of developing AD.
Copyright 2000 Academic Press.
Similar articles
-
APP intracellular domain is increased and soluble Abeta is reduced with diet-induced hypercholesterolemia in a transgenic mouse model of Alzheimer disease.Neurobiol Dis. 2004 Jun;16(1):124-32. doi: 10.1016/j.nbd.2004.01.009. Neurobiol Dis. 2004. PMID: 15207269
-
High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.Neuroscience. 2009 Mar 3;159(1):296-307. doi: 10.1016/j.neuroscience.2008.12.006. Epub 2008 Dec 14. Neuroscience. 2009. PMID: 19135506
-
Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.J Neurochem. 2004 Aug;90(4):1011-8. doi: 10.1111/j.1471-4159.2004.02532.x. J Neurochem. 2004. PMID: 15287908
-
Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk.Prog Lipid Res. 2010 Apr;49(2):159-70. doi: 10.1016/j.plipres.2009.10.004. Epub 2009 Nov 5. Prog Lipid Res. 2010. PMID: 19896503 Review.
-
Statins: drugs for Alzheimer's disease?J Neural Transm (Vienna). 2005 Aug;112(8):1057-71. doi: 10.1007/s00702-004-0273-1. Epub 2005 Jan 31. J Neural Transm (Vienna). 2005. PMID: 15682268 Review.
Cited by
-
A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease.Neurobiol Aging. 2013 Jun;34(6):1530-9. doi: 10.1016/j.neurobiolaging.2012.11.023. Epub 2012 Dec 29. Neurobiol Aging. 2013. PMID: 23276384 Free PMC article.
-
Decreased Plasma Aβ in Hyperlipidemic APPSL Transgenic Mice Is Associated with BBB Dysfunction.Front Neurosci. 2016 Jun 1;10:232. doi: 10.3389/fnins.2016.00232. eCollection 2016. Front Neurosci. 2016. PMID: 27313503 Free PMC article.
-
Intracellular and extracellular Abeta, a tale of two neuropathologies.Brain Pathol. 2005 Jan;15(1):66-71. doi: 10.1111/j.1750-3639.2005.tb00101.x. Brain Pathol. 2005. PMID: 15779238 Free PMC article. Review.
-
Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease.Neuromolecular Med. 2002;1(1):1-31. doi: 10.1385/NMM:1:1:1. Neuromolecular Med. 2002. PMID: 12025813 Review.
-
Hypothyroidism and Diabetes-Related Dementia: Focused on Neuronal Dysfunction, Insulin Resistance, and Dyslipidemia.Int J Mol Sci. 2022 Mar 10;23(6):2982. doi: 10.3390/ijms23062982. Int J Mol Sci. 2022. PMID: 35328405 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases